NR3C1 and chronic obstructive pulmonary disease: Our hypothesis posits that there exists a variance in the expression levels of GR, the GR-transcription factor complex, and HDACs in ASMC among COPD patients who exhibit responsiveness to ICS versus those who do not respond.